Literature DB >> 7876659

Contrast echocardiography of the left ventricle an independent predictor of pulmonary artery pressure?

R J Zotz1, S Genth, R Erbel, H A Dieterich, J Meyer.   

Abstract

To test the hypothesis that left heart opacification is dependent on pulmonary artery pressure, we analyzed consecutively 12 patients with normal and 8 patients with abnormal pulmonary artery pressure with a new lung capillary stable echo contrast agent. Patients underwent contrast echocardiographic examination within 6 hours before right and left heart catheterization with 200 mg/ml and 400 mg/ml SHU 508A intravenously. The mean pulmonary artery pressure was 15.4 mmHg in the patients with normal pulmonary artery pressures and 46.4 mmHg in the patients with pulmonary hypertension (p < 0.000). Echocardiograms were video-intensitometrically analyzed for intensity maximum (MAX), half-time of video-intensity decay (T1/2), area under the intensity curve (AUC) in the right and left ventricle and transit time from left to right heart (TT). Patients with normal pulmonary artery pressure showed sufficient left heart opacification, in the left ventricle MAX was 37 +/- 15 IU, AUC measured 653 +/- 463 IUxs and T1/2 was 4.4 +/- 2.6 s, while patients with elevated pulmonary artery pressure showed no significant left heart opacification. In the left ventricle MAX was 8 +/- 10 IU (p = 0.006), AUC measured 66 +/- 108 (p = 0.003) and T1/2 was 2.0 +/- 2.0 s (p = 0.041). TT was significantly increased in patients with elevated pulmonary artery pressure (11.8 +/- 4.6 s versus 6.5 +/- 2.8 s in patients with normal pulmonary artery pressure, p = 0.005). Thus, elevated pulmonary pressure has a significant impact on left heart opacification, which may be used for diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7876659     DOI: 10.1007/bf01137901

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  19 in total

1.  Successful opacification of the left heart chambers on echocardiographic examination after intravenous injection of a new saccharide based contrast agent.

Authors:  R Schlief; T Staks; M Mahler; M Rufer; T Fritzsch; W Seifert
Journal:  Echocardiography       Date:  1990-01       Impact factor: 1.724

Review 2.  Myocardial perfusion by contrast echocardiography. From off-line processing to radio frequency analysis.

Authors:  D Rovai; M Lombardi; A Distante; A L'Abbate
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

3.  [Right heart ventriculography using Gelifundol].

Authors:  R Zotz; L Duwe; R Erbel; P Frank; R Brennecke; J Meyer
Journal:  Z Kardiol       Date:  1989-02

4.  Ultrasound cardiography: contrast studies in anatomy and function.

Authors:  R Gramiak; P M Shah; D H Kramer
Journal:  Radiology       Date:  1969-04       Impact factor: 11.105

5.  Physical factors influencing quantitation of two-dimensional contrast echo amplitudes.

Authors:  W Zwehl; J Areeda; G Schwartz; S Feinstein; K Ong; S Meerbaum
Journal:  J Am Coll Cardiol       Date:  1984-07       Impact factor: 24.094

6.  Why do the lungs clear ultrasonic contrast?

Authors:  R S Meltzer; E G Tickner; R L Popp
Journal:  Ultrasound Med Biol       Date:  1980       Impact factor: 2.998

7.  Contrast echocardiographic mapping of collateralized myocardium in humans before and after coronary angioplasty.

Authors:  H P Grill; J A Brinker; J C Taube; G D Walford; M G Midei; J T Flaherty; J L Weiss
Journal:  J Am Coll Cardiol       Date:  1990-12       Impact factor: 24.094

8.  Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?

Authors:  C W White; C B Wright; D B Doty; L F Hiratza; C L Eastham; D G Harrison; M L Marcus
Journal:  N Engl J Med       Date:  1984-03-29       Impact factor: 91.245

9.  Surgical correction of chronic postembolic obstructions of the pulmonary arteries.

Authors:  C Cabrol; A Cabrol; J Acar; I Gandjbakhch; G Guiraudon; L Laughlin; M F Mattei; P Godeau; P Grondin
Journal:  J Thorac Cardiovasc Surg       Date:  1978-11       Impact factor: 5.209

10.  Hyperemic response of intracoronary contrast agents during two-dimensional echographic delineation of regional myocardium.

Authors:  S Kondo; C Tei; S Meerbaum; E Corday; P M Shah
Journal:  J Am Coll Cardiol       Date:  1984-07       Impact factor: 24.094

View more
  1 in total

1.  Immunological evaluation of the new stable ultrasound contrast agent LK565: a phase one clinical trial.

Authors:  B Funke; H K Maerz; S Okorokow; S Polata; I Lehmann; U Sack; P Wild; T Geisler; R J Zotz
Journal:  Cardiovasc Ultrasound       Date:  2004-09-10       Impact factor: 2.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.